462 related articles for article (PubMed ID: 21501630)
1. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
[TBL] [Abstract][Full Text] [Related]
3. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
[TBL] [Abstract][Full Text] [Related]
5. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
[TBL] [Abstract][Full Text] [Related]
8. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
[TBL] [Abstract][Full Text] [Related]
10. Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander.
Walkden-Brown SW; Islam A; Islam AF; Burgess SK; Groves PJ; Cooke J
Aust Vet J; 2013 Aug; 91(8):341-50. PubMed ID: 23889101
[TBL] [Abstract][Full Text] [Related]
11. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
Sharma JM; Witter RL
Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
[TBL] [Abstract][Full Text] [Related]
12. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
14. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.
Quéré P; Rivas C; Ester K; Novak R; Ragland WL
Arch Virol; 2005 Mar; 150(3):507-19. PubMed ID: 15592893
[TBL] [Abstract][Full Text] [Related]
15. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
Sharma JM; Graham CK
Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
[TBL] [Abstract][Full Text] [Related]
16. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
Haq K; Fear T; Ibraheem A; Abdul-Careem MF; Sharif S
Avian Pathol; 2012; 41(1):69-75. PubMed ID: 22845323
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.
Fakhrul Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
Avian Pathol; 2008 Jun; 37(3):225-35. PubMed ID: 18568648
[TBL] [Abstract][Full Text] [Related]
18. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
[TBL] [Abstract][Full Text] [Related]
19. Effects of T-2 Toxin on Turkey Herpesvirus-Induced Vaccinal Immunity Against Marek's Disease.
Kufuor-Mensah E; Reed WM; Sleight S; Pestka J; Fadly AM; Dunn JR
Avian Dis; 2016 Mar; 60(1):56-62. PubMed ID: 26953944
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pre-Treatment with a Recombinant Chicken Interleukin-17A on Vaccine Induced Immunity against a Very Virulent Marek's Disease Virus.
Boodhoo N; Matsuyama-Kato A; Raj S; Fazel F; St-Denis M; Sharif S
Viruses; 2023 Jul; 15(8):. PubMed ID: 37631976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
